Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Vomiting Vomiting was reported in about 30.9% of patients in the OASIS 4 trial, compared to 5.9% on placebo, and was more common during the dose-escalation period
Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, Campos RR
Protein itself has a minimal effect on raising blood sugar levels
Regular monitoring, patient education, and a willingness to adjust treatment plans as needed are essential components of effective care
There is limited clinical evidence supporting the effectiveness of specific remedies for common side effects in this patient population, although standard over-the-counter therapies for nausea and constipation are traditionally recommended as initial steps [7]
ALCAR has not received the large-scale trials Cymbalta has in fibromyalgia
